| Name | Title | Contact Details |
|---|
Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient`s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.
The CVMC Care Team is over 600 members strong, with nearly 40 active medical staff professionals and approximately 100 courtesy, consulting and Emergency Department staff members. 19 areas of medical specialization are currently represented through the state-of-the-art 248-bed facility, with plans for added services on the horizon. As an independent, non-profit hospital, CVMC is solely focused on delivering the highest quality of health care to Sylacauga and its surrounding communities.
Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore with offices in North Carolina, New York City, London, Malaysia and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk`s vision is to build the world`s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools. Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.
Excellance Inc is a Madison, AL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company`s leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.